Skip to content
10-K

Annual Report

BIOSCIENCE HEALTH INNOVATIONS INC. BHIC

0001185185-26-001133

← back to feed
Filed
Mar 30, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 27, 2026 11.37M sh
Shares Diluted FY 2025 · Dec 31, 2025 11.4M sh
Shares Diluted restated FY 2025 · Dec 31, 2024 10.9M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 $172.18K
Operating Cash Flow FY 2025 · Dec 31, 2024 $23.19K
Cash And Equivalents FY 2025 · Dec 31, 2025 $661.93K
Cash And Equivalents FY 2025 · Dec 31, 2024 $662.52K
Stockholders Equity FY 2025 · Dec 31, 2025 $1.48M
Stockholders Equity FY 2025 · Dec 31, 2024 $835.24K
Stockholders Equity FY 2025 · Dec 31, 2023 −$6.76K
Total Liabilities FY 2025 · Dec 31, 2025 $229.85K
Total Liabilities FY 2025 · Dec 31, 2024 $38.55K
Current Assets FY 2025 · Dec 31, 2025 $1.56M
Current Assets FY 2025 · Dec 31, 2024 $847.75K
Total Assets FY 2025 · Dec 31, 2025 $1.71M
Total Assets FY 2025 · Dec 31, 2024 $873.79K
Eps Diluted FY 2025 · Dec 31, 2025 $0.06
Eps Diluted restated FY 2025 · Dec 31, 2024 $0.01
Eps Basic FY 2025 · Dec 31, 2025 $0.06
Eps Basic restated FY 2025 · Dec 31, 2024 $0.01
Sga Expense FY 2025 · Dec 31, 2025 $2.21M
Sga Expense FY 2025 · Dec 31, 2024 $1.15M
Rd Expense FY 2025 · Dec 31, 2025 $161.35K
Rd Expense FY 2025 · Dec 31, 2024 $25.91K
Net Income FY 2025 · Dec 31, 2025 $642.09K
Net Income FY 2025 · Dec 31, 2024 $87K
Operating Income FY 2025 · Dec 31, 2025 $719.05K
Operating Income FY 2025 · Dec 31, 2024 $87K
Gross Profit FY 2025 · Dec 31, 2025 $3.24M
Gross Profit FY 2025 · Dec 31, 2024 $1.31M
Cost Of Revenue FY 2025 · Dec 31, 2025 $2.45M
Cost Of Revenue FY 2025 · Dec 31, 2024 $536.08K
Revenue FY 2025 · Dec 31, 2025 $5.69M
Revenue FY 2025 · Dec 31, 2024 $1.84M